Point View Wealth Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $254K | Sell |
5,517
-238
| -4% | -$11K | 0.1% | 223 |
|
|
2020
Q3 | $271K | Buy |
5,755
+130
| +2% | +$6.12K | 0.13% | 201 |
|
|
2020
Q2 | $287K | Sell |
5,625
-691
| -11% | -$35.3K | 0.14% | 192 |
|
|
2020
Q1 | $299K | Sell |
6,316
-683
| -10% | -$32.3K | 0.16% | 178 |
|
|
2019
Q4 | $411K | Sell |
6,999
-716
| -9% | -$42K | 0.17% | 175 |
|
|
2019
Q3 | $412K | Sell |
7,715
-1,743
| -18% | -$93.1K | 0.19% | 161 |
|
|
2019
Q2 | $473K | Hold |
9,458
| – | – | 0.2% | 147 |
|
|
2019
Q1 | $494K | Sell |
9,458
-302
| -3% | -$15.8K | 0.22% | 142 |
|
|
2018
Q4 | $466K | Sell |
9,760
-594
| -6% | -$28.4K | 0.24% | 133 |
|
|
2018
Q3 | $520K | Buy |
10,354
+648
| +7% | +$32.5K | 0.23% | 142 |
|
|
2018
Q2 | $489K | Buy |
9,706
+432
| +5% | +$21.8K | 0.23% | 144 |
|
|
2018
Q1 | $453K | Buy |
9,274
+345
| +4% | +$16.9K | 0.22% | 145 |
|
|
2017
Q4 | $396K | Buy |
8,929
+856
| +11% | +$38K | 0.19% | 157 |
|
|
2017
Q3 | $410K | Buy |
8,073
+987
| +14% | +$50.1K | 0.2% | 157 |
|
|
2017
Q2 | $382K | Buy |
7,086
+1,317
| +23% | +$71K | 0.19% | 159 |
|
|
2017
Q1 | $304K | Buy |
5,769
+656
| +13% | +$34.6K | 0.16% | 176 |
|
|
2016
Q4 | $246K | Sell |
5,113
-59
| -1% | -$2.84K | 0.14% | 184 |
|
|
2016
Q3 | $279K | Sell |
5,172
-82
| -2% | -$4.42K | 0.17% | 173 |
|
|
2016
Q2 | $285K | Buy |
5,254
+311
| +6% | +$16.9K | 0.17% | 168 |
|
|
2016
Q1 | $251K | Buy |
+4,943
| New | +$251K | 0.16% | 176 |
|